Cartalax

Cartalax is a synthetic short-chain peptide (a Khavinson-type bioregulator) supplied as a lyophilised powder strictly as a reference compound for in-vitro laboratory and analytical research.

Research context (literature reference only)

Published preclinical literature has investigated Cartalax in in-vitro connective-tissue and extracellular-matrix research models. These references are provided solely to contextualise the compound as a laboratory reference standard and do not describe, and must not be interpreted as, any effect, benefit or outcome in humans.

Specifications

• Appearance: White to off-white lyophilised powder
• Purity: ≥98% (HPLC)
• Format: Lyophilised powder
• Vial Size: 3ml
• Solubility: Soluble in bacteriostatic water
• Storage: Lyophilised at −20 °C; after reconstitution 2–8 °C

Laboratory handling & storage

Store lyophilised at −20 °C; after reconstitution in bacteriostatic water, store at 2–8 °C. Reconstitution and handling information is provided for laboratory reference only and is not administration guidance.

Frequently asked questions

What purity is Cartalax supplied at?
Cartalax is supplied at ≥98% (HPLC), independently HPLC-verified. A Certificate of Analysis for each batch is published on our Lab Tests page.

Is a Certificate of Analysis available for Cartalax?
Yes – every batch of Cartalax is third-party tested and the COA is available on our Lab Tests page.

How is Cartalax stored and shipped?
Cartalax ships from the UK. Store as noted in the specifications; reconstitution information (where applicable) is a laboratory handling reference only, using bacteriostatic water.